Wilson Therapeutics AB (publ) is a Swedish public limited liability company listed on Nasdaq Stockholm. The company complies with Nasdaq Stockholm’s Rule Book for Issuers and applies the Swedish Corporate Governance Code (the “Code”).
The Code applies to all companies with shares listed on a regulated market in Sweden. Wilson Therapeutics is not obliged to comply with every rule in the Code as the Code itself provides for the possibility to deviate from the rules, provided that any such deviations and the chosen alternative solutions are described and the reasons therefore are explained in the corporate governance report (according to the so-called “comply or explain principle”).
Wilson Therapeutics will report any deviation from the Code in the company’s corporate governance report. Currently, the company does not expect to report any deviation from the Code in the corporate governance report.